|
1
|
Li H, Jin X, Liu P and Hong W: Time to
local recurrence as a predictor of survival in unrecetable gastric
cancer patients after radical gastrectomy. Oncotarget.
8:89203–89213. 2017.PubMed/NCBI
|
|
2
|
Maciejowski J and de Lange T: Telomeres in
cancer: Tumour suppression and genome instability. Nat Rev Mol Cell
Biol. 18:175–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inamura K: Major tumor suppressor and
oncogenic non-coding RNAs: Clinical relevance in lung cancer.
Cells. 6:122017. View Article : Google Scholar
|
|
4
|
Manders DB, Kishore HA, Gazdar AF, Keller
PW, Tsunezumi J, Yanagisawa H, Lea J and Word RA: Dysregulation of
fibulin-5 and matrix metalloproteases in epithelial ovarian cancer.
Oncotarget. 9:14251–14267. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lisi S, DAmore M, Scagliusi P, Mitolo V
and Sisto M: Anti-Ro/SSA autoantibody-mediated regulation of
extracellular matrix fibulins in human epithelial cells of the
salivary gland. Scand J Rheumatol. 38:198–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan H, Zhang J, Fu D and Zhu Y: Loss of
fibulin-2 expression is involved in the inhibition of breast cancer
invasion and forms a new barrier in addition to the basement
membrane. Oncol Lett. 14:2663–2668. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Melnik S, Dvornikov D, Müller-Decker K,
Depner S, Stannek P, Meister M, Warth A, Thomas M, Muley T, Risch
A, et al: Cancer cell specific inhibition of Wnt/β-catenin
signaling by forced intracellular acidification. Cell Discov.
4:372018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long
LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric
tumorigenesis by stabilizing the β-catenin destruction complex.
Gastroenterology. 142:812–823.e15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siersema PD: Esophageal cancer.
Gastroenterol Clin North Am. 37:pp. 943–964, x. 2008, https://doi.org/10.1016/j.gtc.2008.09.012
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yi CH, Smith DJ, West WW and Hollingsworth
MA: Loss of fibulin-2 expression is associated with breast cancer
progression. Am J Pathol. 170:1535–1545. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khan SA, Dong H, Joyce J, Sasaki T, Chu ML
and Tsuda T: Fibulin-2 is essential for angiotensin II-induced
myocardial fibrosis mediated by transforming growth factor (TGF)-β.
Lab Invest. 96:773–783. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fontanil T, Rúa S, Llamazares M,
Moncada-Pazos A, Quirós PM, García-Suárez O, Vega JA, Sasaki T,
Mohamedi Y, Esteban MM, et al: Interaction between the ADAMTS-12
metalloprotease and fibulin-2 induces tumor-suppressive effects in
breast cancer cells. Oncotarget. 5:1253–1264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen R, Yi EC, Donohoe S, Pan S, Eng J,
Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, et al:
Pancreatic cancer proteome: The proteins that underlie invasion,
metastasis, and immunologic escape. Gastroenterology.
129:1187–1197. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fontanil T, Álvarez-Teijeiro S, Villaronga
MÁ, Mohamedi Y, Solares L, Moncada-Pazos A, Vega JA, García-Suárez
O, Pérez-Basterrechea M, García-Pedrero JM, et al: Cleavage of
Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to
the tumorigenic potential of breast cancer cells. Oncotarget.
8:13716–13729. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hergeth SP, Aicher WK, Essl M, Schreiber
TD, Sasaki T and Klein G: Characterization and functional analysis
of osteoblast-derived fibulins in the human hematopoietic stem cell
niche. Exp Hematol. 36:1022–1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Fu L, Zhang LY, Kwong DL, Yan L
and Guan XY: Tumor suppressor genes on frequently deleted
chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer.
31:215–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Argraves WS, Greene LM, Cooley MA and
Gallagher WM: Fibulins: Physiological and disease perspectives.
EMBO Rep. 4:1127–1131. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng YY, Jin H, Liu X, Siu JM, Wong YP,
Ng EK, Yu J, Leung WK, Sung JJ and Chan FK: Fibulin 1 is
downregulated through promoter hypermethylation in gastric cancer.
Br J Cancer. 99:2083–2087. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Austinat M, Dunsch R, Wittekind C,
Tannapfel A, Gebhardt R and Gaunitz F: Correlation between
beta-catenin mutations and expression of Wnt-signaling target genes
in hepatocellular carcinoma. Mol Cancer. 7:212008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCracken KW, Aihara E, Martin B, Crawford
CM, Broda T, Treguier J, Zhang X, Shannon JM, Montrose MH and Wells
JM: Wnt/β-catenin promotes gastric fundus specification in mice and
humans. Nature. 541:182–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Bai B, Liu L, Ma P, Kong L, Yan J,
Zhang J, Ye Z, Zhou H, Mao B, et al: Novel β-carbolines against
colorectal cancer cell growth via inhibition of Wnt/β-catenin
signaling. Cell Death Discov. 1:150332015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown K, Yang P, Salvador D, Kulikauskas
R, Ruohola-Baker H, Robitaille AM, Chien AJ, Moon RT and Sherwood
V: WNT/β-catenin signaling regulates mitochondrial activity to
alter the oncogenic potential of melanoma in a PTEN-dependent
manner. Oncogene. 36:3119–3136. 2017. View Article : Google Scholar : PubMed/NCBI
|
